Mohammed Hussain
Overview
Explore the profile of Mohammed Hussain including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
558
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hussain M, Thaher T, Almourad M, Mafarja M
Sci Rep
. 2024 Dec;
14(1):31759.
PMID: 39738231
Accurate classification of logos is a challenging task in image recognition due to variations in logo size, orientation, and background complexity. Deep learning models, such as VGG16, have demonstrated promising...
2.
Sharma A, Cerdas M, Reza-Soltani S, Rustagi V, Guntipalli M, Rojas Torres D, et al.
Cureus
. 2024 Dec;
16(11):e73119.
PMID: 39650912
Photon-counting computed tomography (PCCT) is an innovative mechanism used for imaging and provides higher spatial resolution and contrast sensitivity in comparison with the orthodox energy-integrating detectors (EIDs). Unlike EID-based CT...
3.
Alsaber A, Al-Herz A, Alawadhi B, Doush I, Setiya P, Al-Sultan A, et al.
Front Big Data
. 2024 Oct;
7:1406365.
PMID: 39421133
Background: Rheumatoid arthritis (RA) is a common condition treated with biological disease-modifying anti-rheumatic medicines (bDMARDs). However, many patients exhibit resistance, necessitating the use of machine learning models to predict remissions...
4.
Alkhudir D, Al-Herz A, Saleh K, Alawadhi A, Al-Kandari W, Hasan E, et al.
Open Access Rheumatol
. 2023 Nov;
15:223-230.
PMID: 38026718
Background: An association between serum uric acid (UA) and disease activity in rheumatoid arthritis (RA) patients has not been well studied. We describe RA patients with high and normal UA...
5.
Alawadhi B, Alsaber A, Shatawan I, Al-Herz A, Setiya P, Saleh K, et al.
Int J Rheum Dis
. 2023 Oct;
26(12):2430-2440.
PMID: 37784239
Background: Rheumatoid arthritis (RA) is a chronic, autoimmune disease that mostly affects the synovial joints. It has been hypothesized that dietary and other environmental and lifestyle factors contribute to the...
6.
Holden D, May C, Robbins B, Cook A, Jung S, Smetana K, et al.
Interv Neuroradiol
. 2023 Jul;
:15910199231180003.
PMID: 37402388
Background: Emergent neuroendovascular stenting presents challenges for the utilization of antiplatelet agents. Methods: This was a multicenter, retrospective cohort of patients who underwent emergent neuroendovascular stenting. The primary endpoints were...
7.
May C, Holden D, Robbins B, Cook A, Jung S, Smetana K, et al.
Neurocrit Care
. 2023 Jun;
40(1):262-271.
PMID: 37322326
Background: Dual antiplatelet therapy (DAPT) is commonly employed for neuroendovascular stenting due to the significant risk of thromboembolism. Clopidogrel and aspirin are most often selected as initial DAPTs; however, there...
8.
Cheng Z, Geng X, Tong Y, Dornbos 3rd D, Hussain M, Rajah G, et al.
Neurotherapeutics
. 2021 Jan;
18(2):1188-1197.
PMID: 33410112
Adjuvant neuroprotective therapies for acute ischemic stroke (AIS) have demonstrated benefit in animal studies, albeit without human translation. We investigated the safety and efficacy of high-flow normobaric oxygen (NBO) after...
9.
Mair M, Hussain M, Siddiqui S, Das S, Baker A, Conboy P, et al.
Br J Radiol
. 2020 Dec;
94(1119):20201039.
PMID: 33353381
Objective: To perform a systematic review and meta-analysis to compare the diagnostic accuracy of CT and initial reverse transcriptase polymerase chain reaction (RT-PCR) for detecting COVID-19 infection. Methods: We searched...
10.
Al-Herz A, Saleh K, Al-Awadhi A, Al-Kandari W, Hasan E, Ghanem A, et al.
Clin Rheumatol
. 2020 Oct;
40(5):1759-1765.
PMID: 33044725
Objective: Biologics are indicated in rheumatoid arthritis (RA) in case of persistent high disease activity despite conventional disease-modifying anti-rheumatic drugs (cDMARDs) or patients with contraindications to cDMARDs or poor prognostic...